Back to News
Market Impact: 0.15
ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026
Source: globenewswire.com
Healthcare & Biotech
A conference call and webcast is scheduled for October 23, 2026, at 8:00 a.m. ET. Dr. Joshua Sabari will discuss enozertinib clinical data and its potential use for first-line NSCLC patients with EGFR atypical mutations; the announcement provides no specific results or efficacy figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Capital One, General Motors are among the stocks reporting this week with momentum. Here are the others
- Crushed tech stocks bounce — plus, new doctor survey keeps us positive on Lilly
- Merck KGaA to acquire Silence Therapeutics for $1.3 billion
- Disc Medicine surges 38% after bitopertin clears Phase 3 trial endpoints
- Silence Therapeutics jumps 59% on Merck takeover
- Goldman says play defense with these stocks if you're worried about the AI bull failing